Dog /

Breed profile · FDA CVM July 2026 extract

Retriever - Nova Scotia Duck Tolling adverse-event record

Adverse-event filings for Retriever - Nova Scotia Duck Tolling (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

Verify with FDA CVM →
#174 of 510
by report volume (all breeds)
250
FDA CVM reports on file
1.6%
death-coded share of reports
#268 of 275
by death-coded share (≥50 reports)

How the 250 reports break down

By recorded gender -- every report on file for Retriever - Nova Scotia Duck Tolling, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 22 16.5 11 5.5 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Retriever - Nova Scotia Duck Tolling drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Retriever - Nova Scotia Duck Tolling ranks #174 of 510 by total reports (250) and #268 of 275 by death-coded share (1.6%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#174
This breed, reports of 510
#268
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Retriever - Nova Scotia Duck Tolling has 250 reports now versus 248 in that prior snapshot: 2 more (0.8%).

Report change
+2
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Retriever - Nova Scotia Duck Tolling changes

Total Reports

250

Above-median volume

Deaths Reported

4

of 250 reports

Death-coded share of reports

1.6%

Lowest death-coded share

Avg Age at Report

5.7 yr

21.4 kg avg weight

Breed Safety Scorecard

B (70/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate A+
1.6%

Share of reports coded as a fatality

Euthanasia rate A+
0.4%

Share of reports resulting in euthanasia

Full recovery rate C
30.8%

Share of reports coded "Recovered/Normal"

5-year trend F
+75%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Retriever - Nova Scotia Duck Tolling death-coded reports 1.6%
Cross-breed median

1.6% of 250 retriever - nova scotia duck tolling reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Retriever - Nova Scotia Duck Tolling's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

2% 3rd percentile Higher share than 3% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Retriever - Nova Scotia Duck Tolling 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 21.4 kg (47.2 lbs)

Top Reported Reactions

Vomiting 66
Lack of efficacy (endoparasite) - hookworm 22
Diarrhoea 17
Lack of efficacy (bacteria) - Borrelia 15
Lethargy (see also Central nervous system depression in 'Neurological') 13
Lack of efficacy - NOS 13
Lack of efficacy (ectoparasite) - tick NOS 12
Emesis 10

Most Referenced Drugs

Milbemycin Oxime + Spinosad 37
Ivermectin + Pyrantel As Pamoate Salt 36
Milbemycin Oxime + Praziquantel 22
Pyrantel Pamoate;Sarolaner 22
Afoxolaner 20
Fluralaner Chew Tablets 13
Grapiprant 10
Spinosad 8

Outcome Breakdown

Outcome Unknown
90 (38.0%)
Recovered/Normal
77 (32.5%)
Ongoing
58 (24.5%)
Recovered with Sequela
8 (3.4%)
Died
3 (1.3%)
Euthanized
1 (0.4%)

Gender Distribution

Female 128 (51.2%)
Male 113 (45.2%)
Mixed 5 (2.0%)
Unknown 4 (1.6%)

Reports by Year

Year Reports Trend
2010 11
2011 3
2012 7
2013 10
2014 16
2015 15
2016 26
2017 18
2018 22
2019 17
2020 15
2021 12
2022 11
2023 22
2024 22
2025 21
2026 2

Retriever - Nova Scotia Duck Tolling: low death-coded share in the FDA CVM extract

Signature read: Retriever - Nova Scotia Duck Tolling's 1.6% death-coded share is in the lower third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Retriever - Nova Scotia Duck Tolling sits at #174 of 510 by report volume among all breeds and #139 of 298 among dog breeds, with 250 reports and 4 (1.6%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #268 of 275. Mean age at report: 5.7 years, average weight 21.4 kg (47.2 lbs).

Top reported signs: Vomiting (66), Lack of efficacy (endoparasite) - hookworm (22), Diarrhoea (17). Most-referenced drug: Milbemycin Oxime + Spinosad (37 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (36) and Milbemycin Oxime + Praziquantel (22).

Outcome coding on 237 status-recorded reports is dominated by Outcome Unknown (38.0%). Annual submissions ranged 2-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Terrier - Norwich
234 reports · 3.0% death-coded
Shepherd Dog - Dutch
267 reports · 1.1% death-coded
Setter - Gordon
231 reports · 5.2% death-coded
Griffon - French Wire-haired Pointing
227 reports · 0.4% death-coded
Terrier - American Staffordshire
227 reports · 2.2% death-coded
Spaniel - Tibetan
222 reports · 5.0% death-coded

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Retriever - Nova Scotia Duck Tolling, both outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (1.6% death-coded here).

Turkish Angora 1.3% · Cat Hanovarian 2.2% · Horse Warmblood - Dutch 2.7% · Horse Oldenburg 2.8% · Horse

Similar average weight

Nearest other-species breeds by reported average weight (21.4 kg here).

Crossbred Caprine/goat 21.7 kg · Goat Pygmy 20.3 kg · Goat Mixed (Sheep) 24.9 kg · Sheep Wild cat 14.5 kg · Cat

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Retriever - Nova Scotia Duck Tolling? ▼
There are 250 adverse event reports involving Retriever - Nova Scotia Duck Tolling in the FDA database, of which 4 were death-coded (1.6% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Retriever - Nova Scotia Duck Tolling ranks #174 of 510 by report volume among all breeds PlainBreed indexes (#139 of 298 among dog breeds).
Where does Retriever - Nova Scotia Duck Tolling sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Retriever - Nova Scotia Duck Tolling is #174 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #139 of 298. Among breeds with at least 50 reports, its death-coded share ranks #268 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Retriever - Nova Scotia Duck Tolling? ▼
The most commonly reported adverse reactions for Retriever - Nova Scotia Duck Tolling are Vomiting (66 reports), Lack of efficacy (endoparasite) - hookworm (22 reports), Diarrhoea (17 reports), Lack of efficacy (bacteria) - Borrelia (15 reports), Lethargy (see also Central nervous system depression in 'Neurological') (13 reports).
What drugs are most frequently associated with Retriever - Nova Scotia Duck Tolling adverse events? ▼
The drugs most frequently referenced in Retriever - Nova Scotia Duck Tolling adverse event reports are Milbemycin Oxime + Spinosad (37 reports), Ivermectin + Pyrantel As Pamoate Salt (36 reports), Milbemycin Oxime + Praziquantel (22 reports), Pyrantel Pamoate;Sarolaner (22 reports), Afoxolaner (20 reports).
What is the average age of Retriever - Nova Scotia Duck Tolling in adverse event reports? ▼
The average age of Retriever - Nova Scotia Duck Tolling at the time of adverse event reports is 5.7 years, with an average weight of 21.4 kg (47.2 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Retriever - Nova Scotia Duck Tolling (Dog), extract as of July 2026 extract. 250 reports · 4 death-coded (1.6% of reports, not a mortality rate) · #174 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →